Literature DB >> 4983133

The association of rheumatoid arthritis with plasma cell and lymphocytic neoplasms.

G J Goldenberg, F Paraskevas, L G Israels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4983133     DOI： 10.1002/art.1780120604

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  18 in total

1.  Leukemia, lymphoma, and multiple myeloma following selected medical conditions.

Authors:  M M Doody; M S Linet; A G Glass; G D Friedman; L M Pottern; J D Boice; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

Review 2.  Rheumatoid arthritis, malignancy, and paraproteins.

Authors:  C Kelly; H Sykes
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

3.  Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma.

Authors:  Normann Steiner; Georg Göbel; Daniela Michaeler; Anna-Luise Platz; Wolfgang Prokop; Anna Maria Wolf; Dominik Wolf; Christina Duftner; Eberhard Gunsilius
Journal:  Blood Adv       Date:  2021-03-23

4.  Kaposi's sarcoma in a patient with rheumatoid arthritis and polymyositis treated with corticosteroids.

Authors:  S R Weiner; D T Noritake; H E Paulus
Journal:  West J Med       Date:  1988-06

5.  Editorial: Amyloid arthropathy.

Authors: 
Journal:  Br Med J       Date:  1974-02-23

Review 6.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

7.  Primary lymphoproliferative conditions of lung.

Authors:  A R Gibbs; R M Seal
Journal:  Thorax       Date:  1978-04       Impact factor: 9.139

8.  Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases.

Authors:  D P Symmons; M Ahern; P A Bacon; C F Hawkins; P L Amlot; E L Jones; P Prior; D L Scott
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

9.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

10.  Cancer morbidity in rheumatoid arthritis.

Authors:  P Prior; D P Symmons; C F Hawkins; D L Scott; R Brown
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.